Fore Kopi Indonesia Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Fore Kopi Indonesia Tbk. trades at Rp615 (market cap 5.44T, 1.89M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp256 (market cap 715.5B, 30.64M 24h volume). The key difference: Fore Kopi Indonesia Tbk. is far larger — about 7.6× Charlie Hospital Semarang Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (30.64M versus 1.89M). Which is the better fit depends on your goals.
| FORE | RSCH | |
|---|---|---|
Market Cap | 5.44T | 715.5B |
Volume | 1.89M | 30.64M |
Lot | 18.9K | 306.41K |
Turnover | 1.15B | 7.98B |
Average Price | 609.92 | 260.34 |
Value | 1.15B | 7.98B |
Indicative Equilibrium Price | 615 | 256 |
Indicative Equilibrium Volume | 1.29K | 512 |
Trailing returns across standard periods
Latest headlines on both assets
PT Fore Kopi Indonesia Tbk (the Company) was established in Jakarta based on Notarial Deed No. 6 dated July 3, 2018 of Jose Dima Satria, S.H., M.Kn. The Company commenced its commercial operations in August 2018. The controlling shareholder of the Company is EVLab Fore Pte. Ltd., through its ownership in Fore Holdings Pte. Ltd.
Read more on FORE →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →